Merck & Co., Inc.
Dr. Gokhale currently works as Director, Pharmacoepidemiology at Merck. Her research areas of interest include oncology, diabetes pharmacoepidemiology and methods for real-world evidence generation including propensity scores and instrumental variables. Mugdha has a background in pharmacy and health outcomes and earned her PhD in Pharmacoepidemiology from the University of North Carolina. She was recognized in the 2016 Forbes 30 under 30 healthcare list for her work in comparative effectiveness and safety of antidiabetic medications.